Examining the advantages of Asia Pacific for Cell & Gene Therapy clinical trials
The Asia-Pacific region hosted the lion’s share of cell and gene therapy clinical trials initiated in H1 2022. Find out what is drawing biotech organizations to the region and discover the resources being used to support these studies, in your free white paper from Scrip, presented in partnership with Novotech.
Discover why Asia Pacific is the leading region for clinical trial activity in the cell and gene therapy area. Download your free white paper for critical insights into:
- Trends in today’s Asia Pacific Cell & Gene Therapy trials
- Asia Pacific’s advantages for trial sponsors
- Addressing misconceptions about Asia Pacific Cell & Gene Therapy trials
- Forging optimal Asia Pacific CRO partnerships
22 December 2022